NCT02709382View on ClinicalTrials.gov

A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Renal Impairment
Interventions
DRUG

Cefepime and Tazobactam combination

Trial Locations (1)

33136

University of Miami,Division of Clinical Pharmacology, Miami

Sponsors

Lead Sponsor

Wockhardt

Collaborators (1)

Clinartis
All Listed Sponsors
collaborator

Clinartis

INDUSTRY

lead

Wockhardt

INDUSTRY